TrialThe Lancet. Oncology2016

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Corey J Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.